Hypokalemic paralysis due to thyrotoxicosis accompanied by Gitelman's syndrome

dc.contributor.authorBaldane S.
dc.contributor.authorIpekci S.H.
dc.contributor.authorCelik S.
dc.contributor.authorGundogdu A.
dc.contributor.authorKebapcilar L.
dc.date.accessioned2020-03-26T19:08:21Z
dc.date.available2020-03-26T19:08:21Z
dc.date.issued2015
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractA 35-year-old male patient was admitted with fatigue and muscle weakness. He had been on methimazole due to thyrotoxicosis for 2 weeks. Laboratory tests showed overt hyperthyroidism and hypokalemia. Potassium replacement was started with an initial diagnosis of thyrotoxic hypokalemic periodic paralysis. Later on, despite the euthyroid condition and potassium chloride treatment, hypokalemia persisted. Further investigations revealed hyperreninemic hyperaldosteronism. The patient was considered to have Gitelman's syndrome (GS) and all genetic analysis was done. A c. 1145C>T, p.Thr382Met homozygote missense mutation located on solute carrier family 12, member gene 3, exon 9 was detected and GS was confirmed.en_US
dc.identifier.doi10.4103/0971-4065.140719en_US
dc.identifier.endpage105en_US
dc.identifier.issn0971-4065en_US
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage103en_US
dc.identifier.urihttps://dx.doi.org/10.4103/0971-4065.140719
dc.identifier.urihttps://hdl.handle.net/20.500.12395/32826
dc.identifier.volume25en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherMedknow Publicationsen_US
dc.relation.ispartofIndian Journal of Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectGitelman's syndromeen_US
dc.subjecthypokalemic paralysisen_US
dc.subjectthyrotoxicosisen_US
dc.titleHypokalemic paralysis due to thyrotoxicosis accompanied by Gitelman's syndromeen_US
dc.typeArticleen_US

Dosyalar